Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Difloxacin, also known as pefloxacin, is a second-generation, synthetic fluoroquinolone antibiotic used in veterinary medicine. It is structurally related to norfloxacin and has broad-spectrum, concentration-dependent, bactericidal activity. However, its efficacy is not as good as enrofloxacin or pradofloxacin. Difloxacin is a white-cream to yellowish crystalline powder and is a quinolone in which the ethyl group at position 1 of the quinolone has been replaced by a p-fluorophenyl group.

98106-17-3

Post Buying Request

98106-17-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic Acid CAS NO.98106-17-3

    Cas No: 98106-17-3

  • USD $ 1.0-3.0 / Metric Ton

  • 1 Metric Ton

  • 10 Metric Ton/Day

  • Hebei yanxi chemical co.,LTD.
  • Contact Supplier
  • 3-Quinolinecarboxylicacid, 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-/ LIDE PHARMA- Factory supply / Best price

    Cas No: 98106-17-3

  • USD $ 10.0-10.0 / Gram

  • 1 Gram

  • 10 Metric Ton/Day

  • LIDE PHARMACEUTICALS LIMITED
  • Contact Supplier

98106-17-3 Usage

Uses

Used in Veterinary Medicine:
Difloxacin is used as an antibiotic for the treatment of bacterial infections in dogs. It is effective against both Gram-positive and Gram-negative bacteria, and is usually administered as the monohydrochloride salt.

Mechanism of action

Difloxacin mainly acts on bacterial deoxyribonucleic acid (DNA) helicase, inhibiting DNA replication and transcription, thereby affecting the normal shape and function of DNA to achieve bactericidal purposes.

Check Digit Verification of cas no

The CAS Registry Mumber 98106-17-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,1,0 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 98106-17:
(7*9)+(6*8)+(5*1)+(4*0)+(3*6)+(2*1)+(1*7)=143
143 % 10 = 3
So 98106-17-3 is a valid CAS Registry Number.
InChI:InChI=1/C21H19F2N3O3/c1-24-6-8-25(9-7-24)19-11-18-15(10-17(19)23)20(27)16(21(28)29)12-26(18)14-4-2-13(22)3-5-14/h2-5,10-12H,6-9H2,1H3,(H,28,29)

98106-17-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid

1.2 Other means of identification

Product number -
Other names UNII-5Z7OO9FNFD

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:98106-17-3 SDS

98106-17-3Synthetic route

1-methyl-piperazine
109-01-3

1-methyl-piperazine

7-Chloro-6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
98105-79-4

7-Chloro-6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

difloxacin
98106-17-3

difloxacin

Conditions
ConditionsYield
In various solvent(s) at 110℃; for 24h;21.3 g
1-methyl-piperazine
109-01-3

1-methyl-piperazine

ethyl 2,4,5-trifluorobenzoylacetate
98349-24-7

ethyl 2,4,5-trifluorobenzoylacetate

N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

4-fluoroaniline
371-40-4

4-fluoroaniline

difloxacin
98106-17-3

difloxacin

Conditions
ConditionsYield
Yield given. Multistep reaction;
1-methyl-piperazine
109-01-3

1-methyl-piperazine

7-Chloro-6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
98105-79-4

7-Chloro-6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

A

difloxacin
98106-17-3

difloxacin

B

7-Chloro-1-(4-fluoro-phenyl)-6-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

7-Chloro-1-(4-fluoro-phenyl)-6-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

Conditions
ConditionsYield
In dimethylsulfoxide-d6 at 120 - 130℃;A 84 % Spectr.
B 16 % Spectr.
1-methyl-piperazine
109-01-3

1-methyl-piperazine

C20H13BClF2NO7

C20H13BClF2NO7

A

difloxacin
98106-17-3

difloxacin

B

7-Chloro-1-(4-fluoro-phenyl)-6-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

7-Chloro-1-(4-fluoro-phenyl)-6-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid

Conditions
ConditionsYield
With sodium hydroxide 1.) DMSO, 110 deg C, 2 h; 2.) reflux, 1 h; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
2,4-dichloro-5-fluoroacetophenone
704-10-9

2,4-dichloro-5-fluoroacetophenone

difloxacin
98106-17-3

difloxacin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 80 percent / NaH / 1.5 h / 80 °C
2: Ac2O / 2 h / 130 °C
3: CH2Cl2 / 0.5 h / Ambient temperature
4: NaH / 1,2-dimethoxy-ethane / 3 h / 80 °C
5: aq. NaOH / tetrahydrofuran / 1.5 h / 80 °C
6: 21.3 g / various solvent(s) / 24 h / 110 °C
View Scheme
ethyl 2,4-dichloro-5-fluoro-benzoyl-acetate
86483-51-4

ethyl 2,4-dichloro-5-fluoro-benzoyl-acetate

difloxacin
98106-17-3

difloxacin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: Ac2O / 2 h / 130 °C
2: CH2Cl2 / 0.5 h / Ambient temperature
3: NaH / 1,2-dimethoxy-ethane / 3 h / 80 °C
4: aq. NaOH / tetrahydrofuran / 1.5 h / 80 °C
5: 21.3 g / various solvent(s) / 24 h / 110 °C
View Scheme
1-(4'-fluoro-phenyl)-6-fluoro-7-chloro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid ethyl ester
98105-80-7

1-(4'-fluoro-phenyl)-6-fluoro-7-chloro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid ethyl ester

difloxacin
98106-17-3

difloxacin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. NaOH / tetrahydrofuran / 1.5 h / 80 °C
2: 21.3 g / various solvent(s) / 24 h / 110 °C
View Scheme
ethyl 2,4-dichloro-5-fluoro-α-[[(4-fluorophenyl)amino]methylene]-β-oxobenzenepropanoate
98105-65-8

ethyl 2,4-dichloro-5-fluoro-α-[[(4-fluorophenyl)amino]methylene]-β-oxobenzenepropanoate

difloxacin
98106-17-3

difloxacin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: NaH / 1,2-dimethoxy-ethane / 3 h / 80 °C
2: aq. NaOH / tetrahydrofuran / 1.5 h / 80 °C
3: 21.3 g / various solvent(s) / 24 h / 110 °C
View Scheme
2,4-dichloro-alpha(elhoxymethlene)-5-fluoro-beta-oxo-benzene propanoic acid ethyl ester
86483-52-5

2,4-dichloro-alpha(elhoxymethlene)-5-fluoro-beta-oxo-benzene propanoic acid ethyl ester

difloxacin
98106-17-3

difloxacin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: CH2Cl2 / 0.5 h / Ambient temperature
2: NaH / 1,2-dimethoxy-ethane / 3 h / 80 °C
3: aq. NaOH / tetrahydrofuran / 1.5 h / 80 °C
4: 21.3 g / various solvent(s) / 24 h / 110 °C
View Scheme
1-methyl-piperazine
109-01-3

1-methyl-piperazine

6,7-difluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid
103994-99-6

6,7-difluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid

difloxacin
98106-17-3

difloxacin

Conditions
ConditionsYield
With triethylamine In acetonitrile Inert atmosphere; Reflux;
ethyl 2,4,5-trifluorobenzoylacetate
98349-24-7

ethyl 2,4,5-trifluorobenzoylacetate

difloxacin
98106-17-3

difloxacin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: acetic anhydride / Heating
2: dichloromethane / Inert atmosphere
3: sodium hydride / tetrahydrofuran; mineral oil / Inert atmosphere; Heating
4: hydrogenchloride; water; acetic acid / Reflux
5: triethylamine / acetonitrile / Inert atmosphere; Reflux
View Scheme
α-(ethoxymethylene)-2,4,5-trifluoro-β-oxobenzenepropanoic acid, ethyl ester
101799-75-1

α-(ethoxymethylene)-2,4,5-trifluoro-β-oxobenzenepropanoic acid, ethyl ester

difloxacin
98106-17-3

difloxacin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: dichloromethane / Inert atmosphere
2: sodium hydride / tetrahydrofuran; mineral oil / Inert atmosphere; Heating
3: hydrogenchloride; water; acetic acid / Reflux
4: triethylamine / acetonitrile / Inert atmosphere; Reflux
View Scheme
1-(p-fluorophenyl)-6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid ethyl ester
108138-16-5

1-(p-fluorophenyl)-6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid ethyl ester

difloxacin
98106-17-3

difloxacin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogenchloride; water; acetic acid / Reflux
2: triethylamine / acetonitrile / Inert atmosphere; Reflux
View Scheme
ethyl 3-(4-fuoroanilino)-2-(2,4,5-trifuorobenzoyl)acrylate
108115-66-8

ethyl 3-(4-fuoroanilino)-2-(2,4,5-trifuorobenzoyl)acrylate

difloxacin
98106-17-3

difloxacin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium hydride / tetrahydrofuran; mineral oil / Inert atmosphere; Heating
2: hydrogenchloride; water; acetic acid / Reflux
3: triethylamine / acetonitrile / Inert atmosphere; Reflux
View Scheme

98106-17-3Downstream Products

98106-17-3Relevant articles and documents

A high-efficient environment friendly preparation method of quinolone ciprofloxacin drug (by machine translation)

-

Paragraph 0026; 0027; 0028, (2019/01/04)

The invention discloses a high-efficient environmental protection quinolone ciprofloxacin preparation method of drug, is fluorobenzene formyl ethyl acetate, the original carboxylic acid triethyl amine compound as a raw material, the three raw materials into the reactor at a temperature of 90 - 150 °C reaction under 20 - 30 H prepare get quinolone basic parent ring, then adding piperazine, to aminocapronitrile as the solvent, the temperature of the reflux reaction 20 - 28 of H, continue adding 50% sodium hydroxide solution is carboxyl ester hydrolysis to obtain the target compound. The invention is simple in raw material market can buy price is cheap; multi-step reaction link together a pan operation intermediate does not need to separate operation, the reaction process is efficient labor-saving; the whole process of transformation efficiency is high, the final product does not need chromatographic treatment is simple washing can get the pure compound; safety in the course of reaction, after-treatment does not need the eluent separation only needs to ethyl acetate, petroleum ether and methanol washing and can be recycled can be pollution prevention; green reaction process, only ethanol by-product, the atom economy is high; quinolone compounds and high utility value, is important trovafloxacins antibacterial drug composition structure. (by machine translation)

NOVEL METHOD OF SYNTHESIS OF FLUOROQUINOLONES

-

Page/Page column 6; 9, (2009/04/24)

The invention relates to a method of preparation of fluoroquinolones of formula (I) from compounds of formula (II): in which R1, R2, R3, R4, R5, R6, R7, and X are as defined in Claim 1.

Synthesis of [1-15N,2-13C]-labeled difloxacin

Schmidt, Burkhard,Schumacher-Buffel, Ramona,Thiede, Brigitte,Schaeffer, Andreas

, p. 1221 - 1227 (2011/10/02)

The synthesis of [1-15N,2-13C]-difloxacin, an arylfluoroquinolone antibacterial agent, is reported. As a crucial initial step, the starting materials ethyl 2,4,5-trifluorobenzoylacetate, [formyl- 13C]-triethyl orthoformate, and [15N]-4-fluoroaniline were reacted to ethyl [15N,3-13C]-3-(4-fluoroanilino)-2-(2,4, 5-trifluorobenzoyl)acrylate. After cyclization and ester cleavage, the resulting intermediate was reacted with 1-methylpiperazine to [1-15N,2- 13C]-1-(4-fluorophenyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1, 4-dihydro-4-oxoquinoline-3-carboxylate, i.e., [1-15N,2- 13C]-difloxacin. The overall yield was 62% based on the non-labeled and 43% based on the labeled starting materials (both used in 1.4 molar excess). The product was identified by 1H-, 13C-, and 15N-NMR spectroscopy and by cochromatography (TLC, HPLC) with an authentic reference; its purity (HPLC) was above 98%. Prior to synthesis of [1-15N,2-13C]-difloxacin, non-labeled difloxacin was synthesized in order to optimize procedures and to identify and characterize all intermediates.

Regioselective nucleophilic substitution of halogen derivatives of 1-substituted 4-oxo-1,4-dihydroquinoline-3-carboxylic acids

Hermecz, Istvan,Vasvari-Debreczy, Lelle,Podanyi, Benjamin,Kereszturi, Geza,Balogh, Maria,Horvath, Agnes,Varkonyi, Peter

, p. 1111 - 1116 (2007/10/03)

The rate of the nucleophilic displacement of the fluoro atom of 7-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate could be enhanced either by the introduction of further fluoro atom(s) into position(s) 6 and/or 8, or by the formation of a boron chelate (e.g. 3). The regioselectivity of the nucleophilic substitution of the chloro atom in 1-substituted 6-fluoro-7-chloro-4-oxo-1,4dihydroquinoline-3-carboxylic acids could also be enhanced by the formation of a boron chelate (e.g. 7).

A solid phase approach to quinolones using the DIVERSOMER technology

MacDonald, Alasdair A.,DeWitt, Sheila H.,Hogan, Eleonora M.,Ramage, Robert

, p. 4815 - 4818 (2007/10/03)

The first example of a library of the quinolone antibacterial agents prepared by solid phase organic synthesis is described. Results of these studies and the parallel synthesis, isolation, purification and analysis of eight quinolones are discussed.

Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds and compositions thereof

-

, (2008/06/13)

Novel 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds of the formula: STR1 wherein R is hydrogen atom or fluorine atom, R° is hydroxy, fluorine atom or an alkanoyloxy having 1 to 6 carbon atoms, and X1 is hydrogen atom or fluorine atom, and a pharmaceutically acceptable salt thereof, said compounds having excellent antimicrobial activity and hence being useful as an antimicrobial agent, and a pharmaceutical composition comprising as an active ingredient said 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds or a pharmaceutically acceptable salt thereof in admixture with a pharmaceutically acceptable diluent or carrier.

Synthesis and Structure-Activity Relationships of Novel Arylfluoroquinolone Antibacterial Agents

Chu, Daniel T. W.,Fernandes, Prabhavathi B.,Claiborne, Akiyo K.,Pihuleac, Eva,Nordeen, Carl W.,et al.

, p. 1558 - 1564 (2007/10/02)

A series of novel arylfluoroquinolones has been prepared.These derivatives are characterized by having a fluorine atom at the 6-position, substituted amino groups at the 7-position, and substituted phenyl groups at the 1-position.Structure-activity relationship (SAR) studies indicate that the in vitro antibacterial potency is greatest when the 1-substituent is either p-fluorophenyl or p-hydroxyphenyl and the 7-substituent is either 1-piperazinyl, 4-methyl-1-piperazinyl, or 3-amino-1-pyrrolidinyl.The electronic and spatial properties of the 1-substituent, as well as the steric bulk, play important roles in the antimicrobial potency in this class of antibacterials.As a result of this study, compounds 45 and 41 were found to possess excellent in vitro potency and in vivo efficacy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 98106-17-3
  • ©2008 LookChem.com,License:ICP NO.:Zhejiang16009103 complaints:service@lookchem.com
  • [Hangzhou]86-0571-87562588,87562578,87562573 Our Legal adviser: Lawyer